Palantir Analysts Deeply Divided on Valuation Ahead of Q2 Earnings

Palantir Technologies (NYSE: PLTR) is a battleground stock on Wall Street, with analysts offering starkly conflicting views on its future as the company prepares to report second-quarter earnings on August 3. Despite a nearly 25% decline year-to-date, price targets from major firms span a massive range from $70 to $255, underscoring a deep disagreement over the data analytics company's rich valuation versus its rapid growth.

Wall Street's Polarized Outlook

The division among analysts is one of the widest in the tech sector. On the bearish end, Jefferies maintains an "Underperform" rating with a $70 price target, implying a potential 49% downside from current levels. Conversely, BofA Securities holds a "Buy" rating with a $255 target, suggesting an 87% upside.

Other firms fall somewhere in between, including Baird Equity Research ("Outperform," $200) and Mizuho Securities ("Neutral," $205). Adding to the bullish momentum, Citi recently named Palantir a top software pick ahead of its earnings, citing AI-driven data infrastructure as a key theme, a notable shift from its previous "Neutral/High Risk" stance. DA Davidson also recently upgraded the stock to "Buy."

The Bull Case: Explosive Growth

Bulls point to Palantir's exceptional growth metrics as justification for their optimism. The company's fundamentals remain strong, highlighted by impressive first-quarter 2026 results:

Ad

• Total revenue grew 85% year-over-year.
• U.S. commercial revenue surged 121%.
• The company guided for full-year 2026 revenue of $7.18 billion to $7.20 billion.

Furthermore, Palantir is expanding its reach through new partnerships with firms like Rackspace and GNP Seguros, marking its debut in Latin America. Proponents argue that with penetration at just 2.4% of its total addressable market, the company has a long runway for growth.

The Bear Case: Valuation and Headwinds

The primary weapon for bears is Palantir's steep valuation. Trading at over 130 times trailing earnings and between 50 and 90 times forward revenue, the stock's multiples leave virtually no margin for error. A slight moderation in growth could trigger a significant multiple compression, a scenario reflected in Jefferies' bearish target.

Recent events have compounded the pressure. A broad AI sector sell-off on July 8 pushed the stock down over 4%. Additionally, recent insider sales by the CTO and a director, though conducted under pre-arranged 10b5-1 plans, have weighed on sentiment. In the U.K., the company also faces geopolitical risk from a court challenge over a police contract and a parliamentary recommendation for a break clause in a major NHS deal.